Annual CFF
$592.00 K
-$4.24 M-87.74%
September 30, 2024
Summary
- As of February 25, 2025, EDSA annual cash flow from financing activities is $592.00 thousand, with the most recent change of -$4.24 million (-87.74%) on September 30, 2024.
- During the last 3 years, EDSA annual CFF has fallen by -$13.58 million (-95.82%).
- EDSA annual CFF is now -95.82% below its all-time high of $14.17 million, reached on September 30, 2021.
Performance
EDSA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.07 M
+$2.10 M+6697.13%
December 31, 2024
Summary
- As of February 25, 2025, EDSA quarterly cash flow from financing activities is $2.07 million, with the most recent change of +$2.10 million (+6697.13%) on December 31, 2024.
- Over the past year, EDSA quarterly CFF has increased by +$1.86 million (+878.51%).
- EDSA quarterly CFF is now -82.65% below its all-time high of $11.94 million, reached on March 31, 2021.
Performance
EDSA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$2.36 M
+$1.77 M+298.28%
December 31, 2024
Summary
- As of February 25, 2025, EDSA TTM cash flow from financing activities is $2.36 million, with the most recent change of +$1.77 million (+298.28%) on December 31, 2024.
- Over the past year, EDSA TTM CFF has increased by +$686.70 thousand (+41.09%).
- EDSA TTM CFF is now -87.57% below its all-time high of $18.96 million, reached on February 28, 2014.
Performance
EDSA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
EDSA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.7% | +878.5% | +41.1% |
| 3 y3 years | -95.8% | +179.5% | -46.6% |
| 5 y5 years | +100.0% | +179.5% | -46.6% |
EDSA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -95.8% | at low | -80.1% | +6697.1% | -82.4% | +298.3% |
| 5 y | 5-year | -95.8% | -100.0% | -82.7% | +6697.1% | -86.3% | +5139.6% |
| alltime | all time | -95.8% | -100.0% | -82.7% | +6697.1% | -87.6% | -100.0% |
Edesa Biotech Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $2.07 M(-6697.1%) | $2.36 M(+298.3%) |
| Sep 2024 | $592.00 K(-87.7%) | -$31.40 K(-129.6%) | $592.00 K(-42.9%) |
| Jun 2024 | - | $106.00 K(-49.9%) | $1.04 M(-38.0%) |
| Mar 2024 | - | $211.70 K(-30.7%) | $1.67 M(-24.9%) |
| Dec 2023 | - | $305.70 K(-25.9%) | $2.22 M(-54.0%) |
| Sep 2023 | $4.83 M(-58.5%) | $412.50 K(-44.3%) | $4.83 M(+9.3%) |
| Jun 2023 | - | $741.20 K(-3.1%) | $4.42 M(+20.2%) |
| Mar 2023 | - | $764.60 K(-73.7%) | $3.68 M(-72.4%) |
| Dec 2022 | - | $2.91 M(<-9900.0%) | $13.31 M(+14.5%) |
| Sep 2022 | $11.63 M(-18.0%) | -$300.00(<-9900.0%) | $11.63 M(-1.9%) |
| Jun 2022 | - | $0.00(-100.0%) | $11.85 M(-0.1%) |
| Mar 2022 | - | $10.40 M(+746.7%) | $11.87 M(-11.5%) |
| Dec 2021 | - | $1.23 M(+455.9%) | $13.41 M(-5.4%) |
| Sep 2021 | $14.17 M(+99.8%) | $221.00 K(+1289.9%) | $14.17 M(-17.5%) |
| Jun 2021 | - | $15.90 K(-99.9%) | $17.18 M(+0.3%) |
| Mar 2021 | - | $11.94 M(+498.6%) | $17.14 M(+89.5%) |
| Dec 2020 | - | $2.00 M(-38.2%) | $9.04 M(+27.5%) |
| Sep 2020 | $7.09 M(>+9900.0%) | $3.23 M(<-9900.0%) | $7.09 M(+83.5%) |
| Jun 2020 | - | -$27.50 K(-100.7%) | $3.86 M(-0.7%) |
| Mar 2020 | - | $3.85 M(+8448.4%) | $3.89 M(+8548.4%) |
| Dec 2019 | - | $45.00 K(>+9900.0%) | $45.00 K(-99.5%) |
| Sep 2019 | $0.00(-100.0%) | - | - |
| Sep 2018 | $8.77 M(>+9900.0%) | $0.00(-100.0%) | $8.77 M(0.0%) |
| Jun 2018 | - | $8.77 M(>+9900.0%) | $8.77 M(>+9900.0%) |
| Sep 2017 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2017 | - | $0.00(-100.0%) | $5.94 M(-18.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | $7.31 M(+6747.4%) | $5.94 M(>+9900.0%) | $7.31 M(+405.6%) |
| Jun 2016 | - | $0.00(0.0%) | $1.45 M(0.0%) |
| Mar 2016 | - | $0.00(-100.0%) | $1.45 M(0.0%) |
| Dec 2015 | - | $1.37 M(+1652.0%) | $1.45 M(+1254.3%) |
| Sep 2015 | $106.80 K(-85.6%) | $78.10 K(>+9900.0%) | $106.80 K(-21.0%) |
| Jun 2015 | - | $0.00(0.0%) | $135.20 K(-10.0%) |
| Mar 2015 | - | $0.00(-100.0%) | $150.30 K(-76.5%) |
| Dec 2014 | - | $28.70 K(-73.1%) | $639.40 K(-94.1%) |
| Sep 2014 | $739.30 K(-93.1%) | - | - |
| Aug 2014 | $10.79 M(+10.9%) | $106.50 K(+605.3%) | $10.79 M(-38.1%) |
| May 2014 | - | $15.10 K(-96.9%) | $17.42 M(-8.1%) |
| Feb 2014 | - | $489.10 K(-95.2%) | $18.96 M(+2.2%) |
| Nov 2013 | - | $10.18 M(+51.0%) | $18.55 M(+90.6%) |
| Aug 2013 | $9.73 M(+1009.3%) | $6.74 M(+332.7%) | $9.73 M(+223.2%) |
| May 2013 | - | $1.56 M(+1896.4%) | $3.01 M(+103.2%) |
| Feb 2013 | - | $78.00 K(-94.3%) | $1.48 M(+5.5%) |
| Nov 2012 | - | $1.36 M(+7235.7%) | $1.40 M(+60.1%) |
| Aug 2012 | $877.20 K(-82.7%) | $18.50 K(-33.7%) | $877.10 K(+1.2%) |
| May 2012 | - | $27.90 K(+2690.0%) | $866.90 K(-7.6%) |
| Feb 2012 | - | $1000.00(-99.9%) | $938.50 K(-20.0%) |
| Nov 2011 | - | $829.70 K(+9896.4%) | $1.17 M(-76.9%) |
| Aug 2011 | $5.07 M(+80.0%) | $8300.00(-91.7%) | $5.07 M(+0.2%) |
| May 2011 | - | $99.50 K(-57.7%) | $5.06 M(+2.0%) |
| Feb 2011 | - | $235.40 K(-95.0%) | $4.96 M(+5.0%) |
| Nov 2010 | - | $4.73 M | $4.73 M |
| Aug 2010 | $2.82 M(+1128.6%) | - | - |
| Apr 2009 | $229.20 K | - | - |
FAQ
- What is Edesa Biotech annual cash flow from financing activities?
- What is the all time high annual CFF for Edesa Biotech?
- What is Edesa Biotech annual CFF year-on-year change?
- What is Edesa Biotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Edesa Biotech?
- What is Edesa Biotech quarterly CFF year-on-year change?
- What is Edesa Biotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for Edesa Biotech?
- What is Edesa Biotech TTM CFF year-on-year change?
What is Edesa Biotech annual cash flow from financing activities?
The current annual CFF of EDSA is $592.00 K
What is the all time high annual CFF for Edesa Biotech?
Edesa Biotech all-time high annual cash flow from financing activities is $14.17 M
What is Edesa Biotech annual CFF year-on-year change?
Over the past year, EDSA annual cash flow from financing activities has changed by -$4.24 M (-87.74%)
What is Edesa Biotech quarterly cash flow from financing activities?
The current quarterly CFF of EDSA is $2.07 M
What is the all time high quarterly CFF for Edesa Biotech?
Edesa Biotech all-time high quarterly cash flow from financing activities is $11.94 M
What is Edesa Biotech quarterly CFF year-on-year change?
Over the past year, EDSA quarterly cash flow from financing activities has changed by +$1.86 M (+878.51%)
What is Edesa Biotech TTM cash flow from financing activities?
The current TTM CFF of EDSA is $2.36 M
What is the all time high TTM CFF for Edesa Biotech?
Edesa Biotech all-time high TTM cash flow from financing activities is $18.96 M
What is Edesa Biotech TTM CFF year-on-year change?
Over the past year, EDSA TTM cash flow from financing activities has changed by +$686.70 K (+41.09%)